Legislative Progress
Introduced
February 25, 2021
Latest Action
April 28, 2021
Primary Sponsor
Christopher H. SmithRepublican(NJ)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
77pct
62d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Informed Consent Act This bill establishes new federal criminal offenses related to the performance of abortions and sterilization procedures. First, the bill prohibits knowingly performing an abortion or sterilization procedure without obtaining informed consent. It provides exceptions, including for an abortion or sterilization procedure that is necessary to save a mother whose life is endangered by a physical (but not psychological or emotional) disorder, illness, or condition. An individual who performs a prohibited abortion or sterilization procedure is subject to criminal penalties—a fine, a prison term of up to 10 years, or both. Second, the bill requires federal employees and contractors, as well as employees and contractors of certain federally funded entities, who know about a prohibited abortion or sterilization procedure to report it as soon as possible. An individual who knows about a prohibited abortion or sterilization procedure but fails to report it is subject to a fine, a prison term of up to three years, or both.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2024 · fourth_quarter · Banking
LEGISLATIVE House H.R. 2798- CFPB Transparency and Accountability Reform Act H.R. 1410- Consumer Financial Protection Commission Act H.R. 1382- TABS Act of 2023 H.R. 1313- Transparency in CFPB Cost-Benefit Analysis Act H.R. 1411- CFPB-IG Reform Act of 2023 H.R. 1165- Data Privacy Act of 2023 H.R. 3881- Credit Card Competition Act of 2023 H.R. 4766- Clarity for Payment Stablecoins Act H.R. 8356- Small Dollar Loan Certainty Act H.R. 8338- Clarity in Lending Act Issues related to implementation of Section 1071 of the Dodd-Frank Act H.R. 4277- Overdraft Protection Act of 2021 (117th Congress) H.R. 6789- Rectifying UDAAP Act H.R. 1810- Bank Loan Privacy Act H.J. Res. 122- Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to "Credit Card Penalty Fees (Regulation Z)" H.R. 7531- Secure Payments Act of 2024 Senate S. 1362- Transparency in CFPB Cost-Benefit Analysis Act S. 1838- Credit Card Competition Act of 2023 S. 2760- Capping Credit Card Interest Rates Act S. 3549- Predatory Lending Elimination Act S. 2482- Community Advantage Loan Program Act S.J. Res. 70- A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to "Credit Card Penalty Fees (Regulation Z)". S. 4570- Secure Payments Act of 2024 Both Chambers Issues related to the cumulative impact of banking regulations, particularly to regional banks Issues related to Zelle payment platform and changes to Regulation E House/Senate semi-annual hearings with the Director of the CFPB Issues related to Financial Services and General Government Appropriations Issues related to consumer data privacy Issues related to regulation of private student loans Legislation related to student loan refinancing programs Issues related to federal student loan reform Issues related to cyber security, data security, and breach notification Issues related to credit card network interchange fees Issues related to financial regulatory coordination Issues related to the Paperwork Reduction Act Issues related to fraud and scams Issues related to the use of artificial intelligence in financial services Issues related to debit interchange Issues related to the CFPBs overdraft final rule Legislation related to the Small Business Administration 7(a) loan program Issues related to the CFPBs Section 1033 final rule Issues related to the CFPBs credit card late fees final rule REGULATORY Privacy Issues, 12 CFR Parts 40, 216, 332, 1016 CFPB Issues related to Section 1033 of the Dodd-Frank Act Issues related to CFPB Credit Card late fees Safe Harbor rule Issues related to UDAAP exam manual changes Issues related to Section 1071 Small Business Data Collection Issues related to Overdraft and non-sufficient funds (NSF) fees Issues related to Fintech oversight Issues related to Section 1034 of the Dodd-Frank Act Issues related to the Fair Credit Reporting Act Issues related to CFPB supervisory authority under Section 1024 Issues related to CFPB agency guidance Issues related to CFPB Consumer Response Portal Issues related to CFPB Taskforce on Consumer Financial Laws Issues related to CFPB UDAAP Authority Issues related to Electronic Fund Transfer Act, regulation E, 15 U.S.C. 1693 Equal Credit Opportunity issues, Regulation B, 12 CFR Part 1002 Home Mortgage Disclosure Act Issues, Regulation C, 12 CFR Part 1003 Fair Credit Reporting Issues, 12 CFR Parts 41, 171, 334, 1022 Truth in Lending Issues, Regulation Z, 12 CFR Part 1026 Fair Debt Collection Practices Issues, Regulation F, 12 CFR Part 1006 Issues related to Buy Now Pay Later products Issues related to Early Wage Access products Issues related to regulation E opt-in requirements OCC Issues related to the Community Reinvestment Act Issues related to fair lending and fair banking Issues related to the Fair Housing Act Issues related to Underbanked/Unbanked Consumers- Consumer Financial Health Issues related to mergers and acquisitions Federal Reserve Issues related to the Federal Reserve Central Digital Bank Currency Issues related to the Community Reinvestment Act Issues related to Basel III Endgame Proposal Issues related to debit interchange, Reg. II FDIC Issues related to FDIC Deposit Insurance Issues related to the Community Reinvestment Act Issues related to FDIC logo signage Issues related to mergers and acquisitions SBA Issues related to Small Business Act Issues related to SBA 7(a) Loan Program and fees Issues related to SBA 504 Loan Program and fees Issues related to the Paycheck Protection Program
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Referred to the House Committee on the Judiciary.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $1,070,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, Small Business Administration (SBA), Treasury, Dept of
2024 · third_quarter · Banking
LEGISLATIVE House H.R. 2798- CFPB Transparency and Accountability Reform Act H.R. 1410- Consumer Financial Protection Commission Act H.R. 1382- TABS Act of 2023 H.R. 1313- Transparency in CFPB Cost-Benefit Analysis Act H.R. 1411- CFPB-IG Reform Act of 2023 H.R. 1165- Data Privacy Act of 2023 H.R. 3881- Credit Card Competition Act of 2023 H.R. 4766- Clarity for Payment Stablecoins Act H.R. 8356- Small Dollar Loan Certainty Act H.R. 8338- Clarity in Lending Act Issues related to implementation of Section 1071 of the Dodd-Frank Act H.R. 4277- Overdraft Protection Act of 2021 (117th Congress) H.R. 6789- Rectifying UDAAP Act H.J.Res. 122- Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to "Credit Card Penalty Fees (Regulation Z)" H.R. 7531- Secure Payments Act of 2024 Senate S. 1362- Transparency in CFPB Cost-Benefit Analysis Act S. 1838- Credit Card Competition Act of 2023 S. 2760- Capping Credit Card Interest Rates Act S. 3549- Predatory Lending Elimination Act S. 2482- Community Advantage Loan Program Act S.J.Res. 70- A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to "Credit Card Penalty Fees (Regulation Z)". S. 4570- Secure Payments Act of 2024 Both Chambers Issues related to the cumulative impact of banking regulations, particularly to regional banks Issues related to Zelle payment platform and changes to Regulation E Issues related to banning arbitration agreements House/Senate Semi-annual Hearings with the Director of the CFPB Issues related to Financial Services and General Government Appropriations Issues related to consumer data privacy Issues related to regulation of private student loans Legislation related to student loan refinancing programs Issues related to federal student loan reform Issues related to cyber security, data security, and breach notification Issues related to credit card network interchange fees Issues related to financial regulatory coordination Issues related to the Paperwork Reduction Act Issues related to fraud and scams Issues related to debit interchange Issues related to overdraft Issues related to the use of artificial intelligence in financial services Legislation related to the Small Business Administration 7(a) loan program REGULATORY Privacy Issues, 12 CFR Parts 40, 216, 332, 1016 CFPB Issues related to Section 1033 of the Dodd-Frank Act Issues related to CFPB Credit Card late fees Safe Harbor rule Issues related to UDAAP exam manual changes Issues related to Section 1071 Small Business Data Collection Issues related to Overdraft and non-sufficient funds (NSF) fees Issues related to Fintech oversight Issues related to Section 1034 of the Dodd-Frank Act Issues related to the Fair Credit Reporting Act Issues related to CFPB supervisory authority under Section 1024 Issues related to CFPB agency guidance Issues related to CFPB Consumer Response Portal Issues related to CFPB Taskforce on Consumer Financial Laws Issues related to Electronic Fund Transfer Act, regulation E, 15 U.S.C. 1693 Equal Credit Opportunity issues, Regulation B, 12 CFR Part 1002 Home Mortgage Disclosure Act Issues, Regulation C, 12 CFR Part 1003 Fair Credit Reporting Issues, 12 CFR Parts 41, 171, 334, 1022 Truth in Lending Issues, Regulation Z, 12 CFR Part 1026 Fair Debt Collection Practices Issues, Regulation F, 12 CFR Part 1006 Issues related to Buy Now Pay Later products Issues related to Early Wage Access products Issues related to regulation E opt-in requirements OCC Issues related to the Community Reinvestment Act Issues related to fair lending and fair banking Issues related to the Fair Housing Act Issues related to Underbanked/Unbanked Consumers- Consumer Financial Health Issues related to mergers and acquisitions Federal Reserve Issues related to the Federal Reserve Central Digital Bank Currency Issues related to the Community Reinvestment Act Issues related to Basel III Endgame Proposal Issues related to debit interchange, Reg. II FDIC Issues related to FDIC Deposit Insurance Issues related to the Bank Secrecy Act and Anti-Money Laundering Issues related to the Community Reinvestment Act Issues related to FDIC logo signage Issues related to mergers and acquisitions SBA Issues related to Small Business Act Issues related to SBA 7(a) Loan Program and fees Issues related to SBA 504 Loan Program and fees Issues related to the Paycheck Protection Program Department of Education Issues related to the CFPBs and Department of Educations actions on student lending
Client expense: $1,040,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), Defense, Dept of (DOD), Education, Dept of, Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, Treasury, Dept of
2024 · second_quarter · Banking
LEGISLATIVE House H.R. 2798- CFPB Transparency and Accountability Reform Act H.R. 1410- Consumer Financial Protection Commission Act H.R. 1382- TABS Act of 2023 H.R. 1313- Transparency in CFPB Cost-Benefit Analysis Act H.R. 1411- CFPB-IG Reform Act of 2023 H.R. 1165- Data Privacy Act of 2023 H.R. 3881- Credit Card Competition Act of 2023 H.R. 4766- Clarity for Payment Stablecoins Act Legislation related to the Small Business Administration 7(a) loan program H.R. 8356- Small Dollar Loan Certainty Act H.R. 8338- Clarity in Lending Act Issues related to implementation of Section 1071 of the Dodd-Frank Act H.R. 4277- Overdraft Protection Act of 2021 (117th Congress) H.R. 6789- Rectifying UDAAP Act H.J.Res. 122- Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to "Credit Card Penalty Fees (Regulation Z)" Senate S. 1362- Transparency in CFPB Cost-Benefit Analysis Act S. 1838- Credit Card Competition Act of 2023 S. 2760- Capping Credit Card Interest Rates Act S. 3549- Predatory Lending Elimination Act S. 2482- Community Advantage Loan Program Act S.J.Res. 70- A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to "Credit Card Penalty Fees (Regulation Z)". Both Chambers Issues related to the cumulative impact of banking regulations, particularly to regional banks Issues related to Zelle payment platform and changes to Regulation E Issues related to banning arbitration agreements House/Senate Semi-annual Hearings with the Director of the CFPB Issues related to Financial Services and General Government Appropriations Issues related to consumer data privacy Issues related to disclosures for federal student loans Legislation related to student loan refinancing programs Issues related to federal student loan reform Issues related to cyber security, data security, and breach notification Issues related to credit card network interchange fees Issues related to financial regulatory coordination Issues related to the Paperwork Reduction Act Issues related to the Higher Education Act Issues related to fraud and scams Issues related to debit interchange Issues related to overdraft Issues related to the use of artificial intelligence in financial services REGULATORY Privacy Issues, 12 CFR Parts 40, 216, 332, 1016 CFPB Issues related to Section 1033 of the Dodd-Frank Act Issues related to CFPB Credit Card late fees Safe Harbor rule Issues related to UDAAP exam manual changes Issues related to Section 1071 Small Business Data Collection Issues related to Overdraft and non-sufficient funds (NSF) fees Issues related to Fintech oversight Issues related to Section 1034 of the Dodd-Frank Act Issues related to the Fair Credit Reporting Act Issues related to CFPB supervisory authority under Section 1024 Issues related to CFPB agency guidance Issues related to CFPB Consumer Response Portal Issues related to CFPB Taskforce on Consumer Financial Laws Issues related to Electronic Fund Transfer Act, regulation E, 15 U.S.C. 1693 Equal Credit Opportunity issues, Regulation B, 12 CFR Part 1002 Home Mortgage Disclosure Act Issues, Regulation C, 12 CFR Part 1003 Fair Credit Reporting Issues, 12 CFR Parts 41, 171, 334, 1022 Truth in Lending Issues, Regulation Z, 12 CFR Part 1026 Fair Debt Collection Practices Issues, Regulation F, 12 CFR Part 1006 OCC Issues related to the Community Reinvestment Act Issues related to fair lending and fair banking Issues related to the Fair Housing Act Issues related to Underbanked/Unbanked Consumers- Consumer Financial Health Federal Reserve Issues related to the Federal Reserve Central Digital Bank Currency Issues related to the Federal Reserve Consumer checking accounts Issues related to the Community Reinvestment Act Issues related to Basel III Endgame Proposal Issues related to debit interchange, Reg. II FDIC Issues related to FDIC Deposit Insurance Issues related to the Bank Secrecy Act and Anti-Money Laundering Issues related to Parent Companies of Industrial Banks and Industrial Loan Companies Issues related to the Community Reinvestment Act Issues related to Section 19 - Criminal Background for prospective employment Issues related to FDIC logo signage SBA Issues related to Small Business Act Issues related to SBA 7(a) Loan Program and fees Issues related to SBA 504 Loan Program and fees Issues related to the Paycheck Protection Program Department of Education Issues related to the CFPBs and Department of Educations actions on student lending
Client expense: $800,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), Defense, Dept of (DOD), Education, Dept of, Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, Treasury, Dept of
2024 · first_quarter · Banking
LEGISLATIVE House H.R. 2798- CFPB Transparency and Accountability Reform Act H.R. 1410- Consumer Financial Protection Commission Act H.R. 1382- TABS Act of 2023 H.R. 1313- Transparency in CFPB Cost-Benefit Analysis Act H.R. 1411- CFPB-IG Reform Act of 2023 H.R. 1165- Data Privacy Act of 2023 H.R. 3881- Credit Card Competition Act of 2023 H.R. 4766- Clarity for Payment Stablecoins Act Legislation related to the Small Business Administration 7(a) loan program Legislation related to small dollar lending Issues related to implementation of Section 1071 of the Dodd-Frank Act H.R. 4277- Overdraft Protection Act of 2021 (117th Congress) H.R. 6789- Rectifying UDAAP Act H.J.Res. 122- Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to "Credit Card Penalty Fees (Regulation Z)" Senate S. 1362- Transparency in CFPB Cost-Benefit Analysis Act S. 1838- Credit Card Competition Act of 2023 S. 2760- Capping Credit Card Interest Rates Act S. 3549- Predatory Lending Elimination Act S. 2482- Community Advantage Loan Program Act S.J.Res. 70- A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to "Credit Card Penalty Fees (Regulation Z)". Both Chambers Issues related to the cumulative impact of banking regulations, particularly to regional banks Issues related to Zelle payment platform and changes to Regulation E Issues related to banning arbitration agreements House/Senate Semi-annual Hearing with the Director of the CFPB Issues related to Financial Services and General Government Appropriations Issues related to consumer data privacy Legislation related to establishing a commission at the CFPB Issues related to disclosures for federal student loans Legislation related to student loan refinancing programs Issues related to federal student loan reform Issues related to cyber security, data security, and breach notification Issues related to credit card network interchange fees Issues related to financial regulatory coordination Issues related to the Paperwork Reduction Act Issues related to the Higher Education Act Issues related to fraud and scams Issues related to the use of artificial intelligence in financial services REGULATORY Privacy Issues, 12 CFR Parts 40, 216, 332, 1016 CFPB Issues related to Section 1033 of Dodd-Frank Issues related to CFPB Credit Card late fees Safe Harbor rule Issues related to UDAAP exam manual changes Issues related to Section 1071 Small Business Data Collection Issues related to Overdraft and non-sufficient funds (NSF) fees Issues related to Fintech oversight Issues related to Section 1034 of Dodd-Frank Act Issues related to the Fair Credit Reporting Act Issues related to CFPB supervisory authority under Section 1024 Issues related to CFPB agency guidance Issues related to CFPB Consumer Response Portal Issues related to CFPB Taskforce on Consumer Financial Laws Issues related to the Servicemembers Civil Relief Act Issues related to the Military Lending Act Issues related to Electronic Fund Transfer Act, regulation E, 15 U.S.C. 1693 Equal Credit Opportunity issues, Regulation B, 12 CFR Part 1002 Home Mortgage Disclosure Act Issues, Regulation C, 12 CFR Part 1003 Fair Credit Reporting Issues, 12 CFR Parts 41, 171, 334, 1022 Truth in Lending Issues, Regulation Z, 12 CFR Part 1026 Fair Debt Collection Practices Issues, Regulation F, 12 CFR Part 1006 OCC Issues related to the Community Reinvestment Act Issues related to fair lending and fair banking Issues related to the Fair Housing Act Issues related to Underbanked/Unbanked Consumers- Consumer Financial Health Federal Reserve Issues related to the Federal Reserve Central Digital Bank Currency Issues related to the Community Reinvestment Act Issues related to Basel III Endgame Proposal Issues related to Debit Interchange Proposals - Reg. II FDIC Issues related to FDIC Deposit Insurance Issues related to the Bank Secrecy Act and Anti-Money Laundering Issues related to the Counter Terrorism & Illicit Finance Act Issues related to the Community Reinvestment Act Issues related to FDIC logo signage SBA Issues related to Small Business Act Issues related to SBA 7(a) Loan Program and fees Issues related to SBA 504 Loan Program and fees Department of Education Issues related to the CFPBs and Department of Educations actions on student lending
Client expense: $1,080,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), Defense, Dept of (DOD), Education, Dept of, Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, Treasury, Dept of
2023 · second_quarter · Banking
4/18 Senate Banking Committee Nominations Hearing 6/13 Senate Banking Committee Hearing- The Consumer Financial Protection Bureaus Semi-Annual Report to Congress 6/14 House Financial Services Committee Hearing- The Semi-Annual Report of the Bureau of Consumer Financial Protection H.R. 2798- CFPB Transparency and Accountability Reform Act H.R. 1410- Consumer Financial Protection Commission Act H.R. 1382- TABS Act of 2023 H.R. 1313- Transparency in CFPB Cost-Benefit Analysis Act S. 1362- Transparency in CFPB Cost-Benefit Analysis Act H.R. 1411- CFPB-IG Reform Act of 2023 H.R. 1165- Data Privacy Act of 2023 S.1838- Credit Card Competition Act of 2023 H.R.3881 - Credit Card Competition Act of 2023 Issues related to Zelle payment platform and changes to Regulation E House Financial Services Discussion Draft: Stablecoin Legislation Issues related to Biden Administration Student Loan Forgiveness Plan Issues related to changing UDAAP legislation/ Dodd-Frank UDAAP provisions Issues related to banning arbitration agreements H.R.2670- National Defense Authorization Act for Fiscal Year 2024 H.R. 8152 - American Data Privacy and Protection Act (117th Congress) H.R. ____ - Protecting Consumers From Payment Scams Act Issues related to Section 1034 of Dodd-Frank Act Issues related to CFPB Credit Card Late Fees and Late Payments H.R.4277 - Overdraft Protection Act of 2021 Issues related to By Now/Pay Later Financial Products Issues related to SBA Direct 7(a) lending program H.R. 6037, To prohibit the Administrator of the Small Business Administration from directly making loans under the 7(a) loan program, and for other purposes. (117th Congress) S. 3382, To prohibit the Administrator of the Small Business Administration from directly making loans under the 7(a) loan program. (117th Congress) S. 3056, the Prohibiting IRS Financial Surveillance Act (117th Congress) House/Senate Semi-annual Hearing with the Director of the CFPB Issues related to Cyber Security, Data Security & Breach Notification Issues related to Consumer Data Privacy Issues related to the Community Reinvestment Act Issues related to fair lending and fair banking Issues related to CFPB supervisory authority under Section 1024 Issues related to Dodd-Frank including Section 1033 H.R. 4773, the Consumer Financial Protection Commission Act (117th Congress) Legislation related to establishing a commission at the CFPB Issues related to CFPB Consumer Response Portal Issues related to CFPB Taskforce on Consumer Financial Laws CFPB Section 1071 rulemaking Issues related to Underbanked/Unbanked Consumers Issues related to CFPB agency guidance Issues related to bank fees, including overdraft fees and credit card late fees. Issues related to credit card network interchange fees. Issues related to the Federal Reserve Central Digital Bank Currency Issues related to the Federal Reserve Consumer checking accounts Issues related to the CFPBs and Department of Educations actions on student lending Issues related to disclosures for federal student loans Legislation related to student loan refinancing programs Issues related to bankruptcy protections for student loans Issues related to federal student loan reform Issues related to AML-BSA Reform Issues related to Appropriations Financial Services and General Government Appropriations Issues related to the Fair Credit Reporting Act Issues related to financial regulatory coordination Issues related to SBA 7(a) Loan Program and fees Issues related to the Fair Housing Act Issues related to Fintech Issues related to the E-SIGN Act Issues related to the Bank Secrecy Act and Anti-Money Laundering Issues related to the Counter Terrorism & Illicit Finance Act Issues related to Parent Companies of Industrial Banks and Industrial Loan Companies Regulations: Equal Credit Opportunity issues, Regulation B, 12 CFR Part 1002 Home Mortgage Disclosure Act Issues, Regulation C, 12 CFR Part 1003 Fair Debt Collection Practices Issues, Regulation F, 12 CFR Part 1006 Privacy Issues, 12 CFR Parts 40, 216, 332, 1016 Fair Credit Reporting Issues, 12 CFR Parts 41, 171, 334, 1022 Truth in Lending Issues, Regulation Z, 12 CFR Part 1026 Regulations related to the Dodd-Frank Act, Pub. L. No. 111-203 Issues related to the Higher Education Act Issues related to Electronic Fund Transfer Act, regulation E, 15 U.S.C. 1693 Issues related to FDIC Deposit Insurance Issues related to the Paperwork Reduction Act Issues related to the Military Lending Act Community Reinvestment Act Regulations & Q&A issues Issues related to the Servicemembers Civil Relief Act Issues related to Small Business Act Issues related to the Bank Secrecy Act and Anti-Money Laundering rules Issues related to Section 1033 of Dodd-Frank Issues related to Overdraft and non-sufficient funds (NSF) fees Issues related to Fintech oversight Issues related to Buy Now Pay Later Issues related to CFPB Credit Card Safe Harbor fee Issues related to Section 1071 Small Business Data Collection Issues related to UDAAP exam manual changes
Client expense: $810,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), Defense, Dept of (DOD), Education, Dept of, Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, Treasury, Dept of
2022 · fourth_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support and Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877), and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3755/H.R.8296) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regard to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76). Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter. Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to legislation (not introduced) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in regard to the Bipartisan Safer Communities Act (S.2938). No position taken. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (S. 4868/H.R. 8851 Providing for Life Act, H.R. 8384/S.4541 Standing with Moms Act, and others). Contacts in regards legislation to respond to violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case. Contacts in opposition to the Build Back Better reconciliation bill (H.R. 5376). H.R. 5376 contains numerous provisions to fund elective abortion in violation of the longstanding principles of the Hyde Amendment, would mandate abortion funding in Affordable Care Act (Obamacare) plans in states that did not expand Medicaid in 2024, and direct billions of dollars to various public health grants without Hyde Amendment protections. Contacts in opposition to the Right to Contraception Act (H.R. 8373) which includes provisions related to the funding of abortion providers and includes language that could permit the use of drugs to induce an abortion weeks or months into a pregnancy. Contacts in opposition to H. Res. 1434 dealing with the preemption of state law in regard to abortion drugs. Contacts regarding H. R. 6878, the Pregnant Women in Custody Act, as it relates to travel for abortion. No position taken.
2022 · third_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877), and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3755/H.R.8296) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76). Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regards to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter. Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome. Contacts in regards to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to legislation (not introduced) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs. Contacts in regards to the Bipartisan Safer Communities Act (S.2938). No position taken. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (S. 4868/H.R. 8851 Providing for Life Act, H.R. 8384/S.4541 Standing with Moms Act, and others). Contacts in regards to violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case. Contacts in regards to the Central American Women and Children Protection Act of 2021 (H.R.4017). No position taken.
2022 · second_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age as well as similar legislation (not introduced). Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts regarding legislation to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in opposition to agency action expanding the use of tissue from aborted babies. Contacts in regards to FDA oversight of prenatal testing products and efficacy. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877), and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion. Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3755/H.R.8296) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76). Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regards to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter. Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome. Contacts in regards to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to legislation (not introduced) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs. Contacts in regards to the Bipartisan Safer Communities Act (S.2938). No position taken. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women. Contacts in regards to violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case. Contacts in regards to the Central American Women and Children Protection Act of 2021 (H.R.4017). No position taken.
2022 · first_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age as well as similar legislation (not introduced). Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts regarding legislation to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in opposition to agency action expanding the use of tissue from aborted babies. Contacts in regards to FDA oversight of prenatal testing products and efficacy. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises. Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion. Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3577) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76). Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regards to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter. Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome.
2021 · fourth_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts regarding legislation to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in opposition to agency action expanding the use of tissue from aborted babies. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises. Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion. Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3577) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss.
2021 · third_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123 ), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts regarding legislation (not introduced) to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620 ). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in opposition to agency action expanding the use of tissue from aborted babies. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises. Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion. Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3577)which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions.
2021 · second_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123 ), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts regarding legislation (not introduced) to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620 ). No position taken. Contacts in opposition to the Paycheck Fairness Act (H.R. 7) because the legislation addresses discrimination based on sex, and there is no rule of construction that would make this legislation abortion-neutral, it is likely that it could be used to sue employers for a lack of elective abortion coverage. Letter sent to House April 13, 2021 and to the Senate June 8, 2021. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in opposition to agency action expanding the use of tissue from aborted babies. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises. Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion. Contacts in support of the Protecting Life in Foreign Assistance Act (S.137/H.R.534) to would ensure that no funds may be made available to foreign non-governmental organizations, multi-lateral nonprofits, and quasi-autonomous non-governmental organizations that perform abortions, counsel for abortion, lobby for abortion policies or expanded access, or provide funding or resources for any entity, including domestic non-governmental organizations and non-profits, that perform abortions abroad. Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Letter sent to the House June 22, 2021.
2021 · second_quarter · Family issues/Abortion/Adoption
H.R. 18, S. 92 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act; H.R. 7 Paycheck Fairness Act; S. 1260 United States Innovation and Competition Act (S. 4049 Endless Frontier Act); S. 1144 Protect Funding for Womens Healthcare Act; S.1382/H.R.2849 Abortion Providers Loan Elimination Act; S. Res. 207/H.Res. 389 National Pregnancy Center Week; Abortion under Department of Veterans Affairs Affairs; President's Budget; House Appropriations - Financial Services and General Government; Agriculture; State and Foreign Operations Appropriations; Commerce, Justice, Science; and Labor, Health and Human Services Appropriations; S. 1975, H.R. 3755 Womens Health Protection Act; H.R. 619, S. 123 Born-Alive Abortion Survivors Protection Act; H.Res. 274 Motion to Discharge from Committee H.R. 619 Born-Alive Abortion Survivors Protection Act; H.R. 51 Washington, D.C. Admission Act; H.R. 1080, S. 61 Pain-Capable Unborn Child Protection Act; Defunding abortion providers; H.R. 1382, S. 446 Informed Consent Act; S.1325/H.R.2782 Womans Right to Know Act; S. 401 Conscience Protection Act; H.R. 554, S. 78 Support and Value Moms and Babies Act; Maternal Mortality; S. 1675, H.R. 4995 Maternal Health Quality Improvement Act; H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act; Chemical abortion; Support services for women; Bioethics; H.R. 5, S. 393 Equality Act; H.R. 1, S. 1/S.2093 For the People Act; Ensuring Access to Equitable, Affordable, Clint-Centered, Quality Family Planning Services (Title X Rule)
Client expense: $200,000 · Firm income: Not reported
2021 · second_quarter · Health Issues
H.R. 18, S. 92 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act; H.R. 7 Paycheck Fairness Act; S. 1260 United States Innovation and Competition Act (S. 4049 Endless Frontier Act); H.R. 2145 SASCA; President's Budget; House Appropriations - Financial Services and General Government; Agriculture; State and Foreign Operations Appropriations; Commerce, Justice, Science; and Labor, Health and Human Services Appropriations; S. 1975, H.R. 3755 Womens Health Protection Act; H.R. 619, S. 123 Born-Alive Abortion Survivors Protection Act; H.Res. 274 Motion to Discharge from Committee H.R. 619 Born-Alive Abortion Survivors Protection Act; H.R. 1080, S. 61 Pain-Capable Unborn Child Protection Act; H.R. 1382, S. 446 Informed Consent Act; S.1325/H.R.2782 Womans Right to Know Act; S. 401 Conscience Protection Act; H.R. 554, S. 78 Support and Value Moms and Babies Act; Maternal Mortality; S. 1675, H.R. 4995 Maternal Health Quality Improvement Act; H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act; Bioethics; Ensuring Access to Equitable, Affordable, Clint-Centered, Quality Family Planning Services (Title X Rule)
Client expense: $200,000 · Firm income: Not reported
2021 · first_quarter · Health Issues
Hyde Amendment; H.R. 705 Heartbeat Protection Act; H.R. 563, S. 77 Protecting Life and Integrity in Research Act; H.R. 619, S. 123 Born-Alive Abortion Survivors Protection Act; H.R. 1080, S. 61 Pain-Capable Unborn Child Protection Act; H.R. 626 Teleabortion Prevention Act; H.R. 532, S. 75 Protecting Individuals with Down Syndrome Act; H.R. 380, S. 124 Abortion Is Not Health Care; H.R. 1382, S. 446 Informed Consent Act; Womans Right to Know Act; S. 401 Conscience Protection Act; H.R. 554, S. 78 Support and Value Moms and Babies Act; H.R. 18, S. 92 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act; Maternal Mortality; Bioethics; Xavier Beccera Nomination; Maternal Health Quality Improvement Act; H.J.Res. 17 Removing the deadline for the ratification of the equal rights amendment; H.R. 1319 American Rescue Plan Act
Client expense: $200,000 · Firm income: Not reported
2021 · first_quarter · Family issues/Abortion/Adoption
Hyde Amendment; H.R. 705 Heartbeat Protection Act; H.R. 563, S. 77 Protecting Life and Integrity in Research Act; H.R. 619, S. 123 Born-Alive Abortion Survivors Protection Act; H.R. 1080, S. 61 Pain-Capable Unborn Child Protection Act; Defunding abortion providers; H.R. 243, S. 88 Title X Abortion Provider Prohibition Act; H.R. 606 No Abortion Bonds Act; H.R. 28 Protecting Life in Crisis Act; H.R. 1011 Life at Conception Act; H.R. 558 Dismemberment Abortion Ban Act; H.R. 626 Teleabortion Prevention Act; H.R. 541 Defund Planned Parenthood Act; H.R. 532, S. 75 Protecting Individuals with Down Syndrome Act; H.R. 380, S. 124 Abortion Is Not Health Care; H.R. 581, S. 2585 Ensuring Accurate and Complete Abortion Data Reporting; H.Res. 60 National Sanctity of Life Day Resolution; H.R. 2223 To prohibit taking minors across State lines in circumvention of laws requiring the involvement of parents in abortion decisions; Adoption Tax Credit Refundability Act; H.R. 1382, S. 446 Informed Consent Act; Keeping Girls in School Act; Womans Right to Know Act; H.R. 1021 No Taxpayer Funding for United Nations Human Rights Council Act; S. 401 Conscience Protection Act; H.R. 554, S. 78 Support and Value Moms and Babies Act; H.R. 18, S. 92 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act; Maternal Mortality; Chemical abortion; Bioethics; Xavier Beccera Nomination; Maternal Health Quality Improvement Act; H.J.Res. 17 Removing the deadline for the ratification of the equal rights amendment; H.R. 1319 American Rescue Plan Act; H.R. 5, S. 393 Equality Act; HR 1; H.R. 1440 Fairness for All Act
Client expense: $200,000 · Firm income: Not reported
2021 · first_quarter · Family issues/Abortion/Adoption
H.R. 1382 Informed Consent Act Modification of medical exceptions for which informed consent must be given prior to performing abortions and sterilizations H.R. 1080 Pain-Capable Unborn Child Protection Act Prohibiting elective abortions at 20 weeks gestation, the point at which unborn babies can feel pain S. 75Protecting Individuals with Down Syndrome ActProhibiting abortions obtained on the basis of a prenatal Down syndrome diagnosis H.R. 563 Protecting Life and Integrity in Research Act of 2021 Prohibiting research using aborted fetal tissue H.R. 554 SAVE Moms and Babies Act of 2021 Maintaining current FDA safety regulations governing chemical abortion H.R. 619 Born-Alive Abortion Survivors Protection Act Requiring physicians to provide appropriate medical care to abortion survivors H.R. 541 Defund Planned Parenthood Act of 2021 Placing a one-year moratorium on federal funding for Planned Parenthood H.R. 581 Ensuring Accurate and Complete Abortion Data Reporting Act of 2021 Requiring accurate abortion data in order to be eligible for Medicaid family planning funding
Client expense: $15,000 · Firm income: Not reported
2021 · first_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123 ), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18) to codify government-wide policy against funding abortion. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts regarding legislation (not introduced) to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620 ). No position taken. Contacts in opposition to the Paycheck Fairness Act (H.R. 7) because the legislation addresses discrimination based on sex, and there is no rule of construction that would make this legislation abortion-neutral, it is likely that it could be used to sue employers for a lack of elective abortion coverage. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in opposition to agency action expanding the use of tissue from aborted babies. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises. Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion. Contacts in support of the Protecting Life in Foreign Assistance Act (S.137/H.R.534) to would ensure that no funds may be made available to foreign non-governmental organizations, multi-lateral nonprofits, and quasi-autonomous non-governmental organizations that perform abortions, counsel for abortion, lobby for abortion policies or expanded access, or provide funding or resources for any entity, including domestic non-governmental organizations and non-profits, that perform abortions abroad. Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion.
| Republican |
| AL |
| Brian Babin | Republican | TX |
| Dusty Johnson | Republican | SD |
| Fred Keller | Republican | PA |
| Glenn Grothman | Republican | WI |
| Gregory F. Murphy | Republican | NC |
| Jackie Walorski | Republican | IN |
| Jaime Herrera Beutler | Republican | WA |
| James R. Baird | Republican | IN |
| Jeff Fortenberry | Republican | NE |
| Jim Banks | Republican | IN |
| John W. Rose | Republican | TN |
| Lauren Boebert | Republican | CO |
| Michelle Fischbach | Republican | MN |
| Mike Johnson | Republican | LA |
| Nancy Mace | Republican | SC |
| Pat Fallon | Republican | TX |
| Ralph Norman | Republican | SC |
| Randy Feenstra | Republican | IA |
| Randy K. Weber, Sr. | Republican | TX |
| Rick W. Allen | Republican | GA |
| Robert B. Aderholt | Republican | AL |
| Robert E. Latta | Republican | OH |
| Roger Williams | Republican | TX |
| Ted Budd | Republican | NC |
| Trent Kelly | Republican | MS |
| W. Gregory Steube | Republican | FL |
| William R. Timmons IV | Republican | SC |
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $30,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Council on Disability, SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $60,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Council on Disability, SENATE